Cary Claiborne
Board Member
Adial Pharmaceuticals, Inc. (ADIL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-12-06–present
-
Current
2021-01-01–present
-
Start not stated–2026-08-13
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Adial Pharmaceuticals, Inc. (ADIL) | Chief Executive Officer and Member of the Board of Directors | $489,250 | $890,653 |
| 2024 | Adial Pharmaceuticals, Inc. (ADIL) | Chief Executive Officer and Member of the Board of Directors | $485,688 | $1,201,339 |
| 2023 | Adial Pharmaceuticals, Inc. (ADIL) | Chief Executive Officer and Member of the Board of Directors | $465,625 | $801,621 |
| 2022 | Adial Pharmaceuticals, Inc. (ADIL) | Chief Executive Officer and Member of the Board of Directors | $356,722 | $1,196,988 |
| 2021 | Adial Pharmaceuticals, Inc. (ADIL) | Chief Executive Officer and Member of the Board of Directors | $15,200 | $466,763 |
| 2020 | Adial Pharmaceuticals, Inc. (ADIL) | Chief Executive Officer since August 18, 2022; Former Chief Operating Officer and Member of the Board of Directors | — | — |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.